The push-to-open mechanism of the tethered mechanosensitive ion channel NompC
- Center for Quantitative Biology, Academy for Advanced Interdisciplinary Studies, Peking University, China
- Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, China
- State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institute of Brain Science, School of Life Sciences, Fudan University, China
- Institute of Molecular Physiology, Shenzhen Bay Laboratory, China
Figures
Figure 1 with 13 supplements
The tethered NompC channel was opened by compression of the intracellular ankyrin repeat domain.
(A) The simulation systems. The NompC was divided into two subsystems, denoted by the cyan and red rectangular boxes, for the molecular dynamics (MD) simulations. (B−D) The transmembrane (TM) pore …
Figure 1—figure supplement 1
The sequence of NompC used for the molecular dynamics (MD) simulations (highlighted).
Figure 1—figure supplement 2
The transmembrane (TM) pore size evolution of multiple replicate simulations with a slower pulling/pushing speed, for the force-free, pulling/stretch, and pushing/compress simulations, calculated from the molecular dynamics (MD) trajectories FI1-3, SI1-3, and CI1-3 (Supplementary file 1a), respectively.
Figure 1—figure supplement 3
This figure is similar to Figure 1B–D except that the pore radius was calculated with the structure of the transmembrane (TM) backbone (side chain removed) in the molecular dynamics (MD) trajectories FI0, SI0, and CI0 (Supplementary file 1a),respectively.
Figure 1—figure supplement 4
This figure is similar to Figure 1—figure supplement 2 except that the pore radius was calculated with the structure of the transmembrane (TM) backbone only (side chain removed) in the molecular dynamics (MD) trajectories FI1-3, SI1-3, and CI1-3, respectively.
Figure 1—figure supplement 5
The number of water molecules around the gate region of NompC in the molecular dynamics (MD) simulations.
Figure 1—figure supplement 6
Sodium ions spontaneously permeated through the partially opened gate in the ‘pushing’ molecular dynamics (MD) simulations in the absence of a transmembrane potential in the trajectories CI1 and CI2, respectively.
Figure 1—figure supplement 7
Ion density maps from the ion permeation trajectories.
The ion density maps were obtained from the simulation trajectories with a −300 mV transmembrane potential for Na+ ions and a 300 mV transmembrane potential for K+ ions, calculated from the …
Figure 1—figure supplement 8
The sodium ion and potassium ion permeation count through the partially opened structure of NompC in the permeation molecular dynamics (MD) trajectories PI1-3 and PII1-3, respectively.
Figure 1—figure supplement 9
Experiment results of the inside-out (IO) and outside-out (OO) patch clamp.
Figure 1—figure supplement 10
The mechanosensitive current can be blocked by GdCl3.
Figure 1—figure supplement 11
Distances between the centers of AR29 and the transmembrane (TM) domain of NompC in the 250 ns molecular dynamics/steered molecular dynamics (MD/SMD) simulations of system I, for the free, pulling, and pushing simulations, calculated from the MD trajectories FI0, SI0, and CI0, respectively.
Figure 1—figure supplement 12
Distances between the centers of AR29 and the transmembrane (TM) domain of NompC in the 500 ns molecular dynamics/steered molecular dynamics (MD/SMD) simulations of system I, for the free, pulling, and pushing simulations, calculated from the MD trajectories FI1-3, SI1-3, and CI1-3, respectively.
Figure 1—figure supplement 13
The overlaid initial and 200 ns conformations of the simulation system I in the free, pulling/stretch, and pushing/compress simulations, from the molecular dynamics (MD) trajectories FI0, SI0, and CI0, respectively.
Figure 2 with 6 supplements
Conformational changes of the transient receptor potential (TRP) and transmembrane (TM) domains during gating.
(A) Principal component analysis (PCA) of the molecular dynamics (MD) simulation trajectories (FI0, SI0, and CI0 in Supplementary file 1a). The projections on the second eigenvector can distinguish …
Figure 2—figure supplement 1
The transmembrane (TM) pore size evolution and rotation angle evolution of the transient receptor potential (TRP) domain from principal component analysis (PCA).
Figure 2—figure supplement 2
The conformational change of the transient receptor potential (TRP) domain in the steered molecular dynamics (SMD) simulations.
The side and bottom views of the S6 and TRP domains before and after pulling or pushing.
Figure 2—figure supplement 3
The overlaid closed-state and open-state structures of TRPV1, obtained in lipid nanodisc.
Figure 2—figure supplement 4
The schematic figure of pUAST-NOMPC_EGFP (del-miniwhite) used in the experiment.
Figure 2—figure supplement 5
The mutants of residues listed in Figure 2D–F showed normal membrane targeting.
Figure 2—figure supplement 6
Formation of the alternative hydrogen bonds in the mutant, as identified in the molecular dynamics (MD) simulations (from chain A in the trajectories D1236A and E1571A in Supplementary file 1a).
Figure 3 with 7 supplements
Mechanical properties of the ankyrin repeat (AR) region.
(A) The simulation system in which the linker helix (LH) domain (orange) was restrained and a pushing or pulling force was applied to the first AR (gray). (B) Projection of the reaction forces of …
Figure 3—figure supplement 1
The forces exerted on the linker helix (LH) domain when AR1 was being pushed/pulled.
Figure 3—figure supplement 2
Steered molecular dynamics (MD) of the single ankyrin repeat (AR) chain of NompC.
Figure 3—figure supplement 3
The force constant of one ankyrin repeat (AR) chain in the AR bundle calculated from the molecular dynamics (MD) simulations with various pulling or pushing forces.
Figure 3—figure supplement 4
The reaction forces to the restraints on the linker helix (LH) domain after applying a force on the AR1.
Figure 3—figure supplement 5
The mutants of residues listed in Figure 3F showed normal membrane targeting.
Figure 3—figure supplement 6
Formation of the alternative hydrogen bonds in the mutant, as identified in the molecular dynamics (MD) simulations (from chain A in the trajectories W1115A in Supplementary file 1a).
Figure 3—figure supplement 7
Formation of the two hydrogen bonds that were not observed in the cryo-EM structure.
Figure 4
A gating model of NompC.
(A) The compression of the ankyrin repeat (AR) region will generate a pushing force and a torque on the linker helix (LH) domain, pointing to the extracellular side. (B) The LH domain further pushes …
Figure 5
The interaction between H1423 and lipids and the effect of adding 1-oleoyl-2-acetyl-sn-glycerol (OAG) on the NompC opening.
(A) The bottom view and (B) the side view of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) molecules moving around H1423. The transient receptor potential (TRP) domain is shown in blue, …
Videos
Video 1
The transmembrane (TM) pore size evolution during the 250 ns simulation trajectories (FI0, SI0, and CI0) as shown in Figure 1B–D.
This video shows the TM pore size evolution during the 250 ns ‘free’, ‘pulling’, and ‘pushing’ simulations.
Video 2
Ion permeation through the partially opened NompC channel under transmembrane potential.
Video 3
The rotation of the transient receptor potential (TRP) domain in the steered molecular dynamics (SMD) simulations (SI0 and CI0 in Supplementary file 1a).
Video 4
The tilt of the transient receptor potential (TRP) domain in the steered molecular dynamics (SMD) simulations (SI0 and CI0 in Supplement 1a).
Video 5
The conformational changes of the AR domain in the “free”, “pulling”, and “pushing” MD simulations as shown in Figure 3C.
Video 6
The conformational changes of the AR domain in the “free”, “pulling”, and “pushing” MD simulations, in which a 2-pN force was applied to each AR chain.
Tables
Key resources table
| Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
|---|---|---|---|---|
| Cell line (D. mel) | Schneider 2 (S2) cells | CCTCC (China Center for Type Culture Collection) | Serial# GDC0138 | Cell species report and Mycoplasma contamination test reports provided |
| Antibody | Rabbit anti-αNOMPC-EC (polyclonoal) | Ref. (Zhang et al., 2015) | Immunostaining dilution (1: 500), primary antibody | |
| Antibody | Alexa Fluor 594 AffiniPure Donkey Anti Rabbit IgG(H + L) | Yeason | Cat# 34212ES60 | Immunostaining dilution (1: 100), secondary antibody |
| Recombinant DNA reagent | pActin-Gal4 (plasmid) | Ref. (Yan et al., 2013) | Plasmid for driving Gal4 expression under actin promoter in S2 cells | |
| Recombinant DNA reagent | pUAST-NOMPC-EGFP (plasmid) | Ref. (Yan et al., 2013) | Plamid for Gal4-driven NompC expression in S2 cells | |
| Recombinant DNA reagent | pUAST-NOMPC-EGFP (del-miniwhite,dm) (plasmid) | This paper | Plamid for Gal4-driven WT NompC expression in S2 cells, no miniwhite sequence | |
| Recombinant DNA reagent | pUAST-NOMPC(D1236A)-EGFP(dm) (plasmid) | This paper | Contains Drosophila NOMPC CDS with alanine substitution on D1236 | |
| Recombinant DNA reagent | pUAST-NOMPC(R1581A)-EGFP(dm) (plasmid) | This paper | Contains Drosophila NOMPC CDS with alanine substitution on R1581 | |
| Recombinant DNA reagent | pUAST-NOMPC(K1244A)-EGFP(dm) (plasmid) | This paper | Contains Drosophila NOMPC CDS with alanine substitution on K1244 | |
| Recombinant DNA reagent | pUAST-NOMPC(E1571A)-EGFP(dm) (plasmid) | This paper | Contains Drosophila NOMPC CDS with alanine substitution on E1571 | |
| Recombinant DNA reagent | pUAST-NOMPC(Q1253A)-EGFP(dm) (plasmid) | This paper | Contains Drosophila NOMPC CDS with alanine substitution on Q1253 | |
| Recombinant DNA reagent | pUAST-NOMPC(S1577A)-EGFP(dm) (plasmid) | This paper | Contains Drosophila NOMPC CDS with alanine substitution on S1577 | |
| Recombinant DNA reagent | pUAST-NOMPC(S1421A)-EGFP(dm) (plasmid) | This paper | Contains Drosophila NOMPC CDS with alanine substitution on S1421 | |
| Recombinant DNA reagent | pUAST-NOMPC(W1572A)-EGFP(dm) (plasmid) | This paper | Contains Drosophila NOMPC CDS with alanine substitution on W1572 | |
| Recombinant DNA reagent | pUAST-NOMPC(W1115A)-EGFP(dm) (plasmid) | This paper | Contains Drosophila NOMPC CDS with alanine substitution on W1115 | |
| Recombinant DNA reagent | pUAST-NOMPC(D1142A)-EGFP(dm) (plasmid) | This paper | Contains Drosophila NOMPC CDS with alanine substitution on D1142 | |
| Recombinant DNA reagent | pUAST-NOMPC(R1127A)-EGFP(dm) (plasmid) | This paper | Contains Drosophila NOMPC CDS with alanine substitution on R1127 | |
| Recombinant DNA reagent | pUAST-NOMPC(E1163A)-EGFP(dm) (plasmid) | This paper | Contains Drosophila NOMPC CDS with alanine substitution on E1163 | |
| Chemical compound, drug | 1-Oleoyl-2-acetyl-sn-glycerol (OAG) | Sigma-Aldrich | Cat# O6754 | DAG analogue |
| Chemical compound, drug | GdCl3 | Sigma-Aldrich | Cat# 439770 | NOMPC blocker |
| Chemical compound, drug | Concanavalin A (Con A) | Sigma-Aldrich | Cat# C5275 | Cell adhesion |
| Chemical compound, drug | ClonExpress II One-step Cloning Kit | Vazyme | Serial# C112 | Site-directed mutagenesis |
| Chemical compound, drug | TransIT-Insect Transfection Reagent | Mirus | Cat# MIR 6100 | S2 cell transfection |
Additional files
-
Supplementary file 1
Tables.
(a) Molecular dynamics/steered molecular dynamics (MD/SMD) trajectories of system I. (b) MD/SMD trajectories of system II. (c) Ion permeation simulations of the partially opened NompC. (d) Stable hydrogen bonds and their occupancies in the MD/SMD trajectories. (e) Different domains/components used in the MD simulations. (f) The primers used for the alanine substitution.
- https://cdn.elifesciences.org/articles/58388/elife-58388-supp1-v1.docx
-
Transparent reporting form
- https://cdn.elifesciences.org/articles/58388/elife-58388-transrepform-v1.docx
